Agent Medical launched ArthroBridge™, an implant for the treatment of hammertoes, and the ArthroMate™ rasp designed for rear foot fusion procedures.
Bone Therapeutics was granted an additional 2MM (~US $2.15MM) in non-dilutive funding, bringing the total non-dilutive funding received within 2015 to 5MM.
Smith+Nephew completed its acquisition of Blue Belt Technologies, developer of the Navio surgical robotics-assistance system for unicondylar knee replacement.
Ortho Kinematics closed US $4MM in debt financing. Funds will support global commercialization of the Vertebral Motion Analysis product for radiographic assessment of spinal motion and instability, as well as launch of new product features.
Bioventus launched DUROLANE® single-injection hyaluronic acid-based osteoarthritis treatment in Taiwan.
Vericel submitted a Biologics License Application to FDA for MACI™ matrix applied characterized autologous cultured chondrocytes, an investigational product intended to treat adult symptomatic cartilage defects of the knee.